CIK 0001828673
- Non-accelerated filer
- Smaller reporting company
- Emerging growth company
HCW Biologics Inc.
Sign in to watch- Ticker
- HCWB
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 825024477
- Phone
- +1 954-842-2024
- Business address
- 2929 N COMMERCE PKWY, MIRAMAR, FL, 33025
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Open-market buy Chief Financial Officer bought 66,452 shares at an average $2.42 ($160,798)
- 4 Open-market buy Chief Executive Officer bought 1,520 shares at $2.19 ($3,326)
- 4 Open-market buy Director bought 3,500 shares at an average $2.19 ($7,673)
- 4 Open-market buy Chief Executive Officer bought 3,000 shares at an average $2.27 ($6,800)
- 4 Open-market buy Director bought 2,000 shares at an average $2.11 ($4,227)
- 4 Open-market buy Director bought 4,800 shares at $2.09 ($10,041)
- 4 Option exercise VP of Development acquired 14,570 shares (option exercise)
- 4 Option exercise See Remarks acquired 1,715 shares (option exercise)
- 4 Open-market buy VP of Development bought 10,000 shares at $2.42 ($24,150)
- 4 Option exercise SVP of Business Development acquired 4,285 shares (option exercise)
- 4 Option exercise Chief Financial Officer acquired 27,000 shares (option exercise)
- 4/A Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 4/A Open-market buy Chief Executive Officer bought 5,830 shares at $3.94 ($22,970)
- 4/A Open-market buy Chief Executive Officer bought 8,000 shares at $3.76 ($30,100)
Page 4 of 6 · 109 filings